Gallacher Capital Management LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1960749 LONE TREE, CO

Position in HALO

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$412,013

-$144,709 QoQ

Shares Held

5,264

-38.9% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#418

of 664 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gallacher Capital Management LLC holds $2,342,787 across 8 Biotechnology names. HALO ranks #2 (17.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	10,486	$570,543
2	HALO	Halozyme Therapeutics, Inc. This page	5,264	$412,013
3	GMAB	Genmab A/S	14,240	$391,172
4	ARGX	Argenx SE	304	$282,042
5	HRMY	Harmony Biosciences Holdings, Inc.	6,666	$242,709
6	BNTX	BioNTech SE	2,448	$227,786
7	INVA	Innoviva, Inc.	9,067	$205,911
8	ANVS	Annovis Bio, Inc.	5,705	$10,611

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$412,013	5,264	-38.9%	Shares	Sole	2026-07-17
2026-03-31	$556,722	8,614	+33.6%	Shares	Sole	2026-05-06
2025-12-31	$433,883	6,447	-29.2%	Shares	Sole	2026-02-03
2025-09-30	$667,834	9,106	+50.6%	Shares	Sole	2025-11-05
2025-06-30	$314,564	6,047	-22.4%	Shares	Sole	2025-07-08
2025-03-31	$497,271	7,793	+19.4%	Shares	Sole	2025-05-05
2024-12-31	$312,008	6,526	+54.1%	Shares	Sole	2025-02-10
2024-09-30	$242,411	4,235	-40.9%	Shares	Sole	2024-11-12
2024-06-30	$375,211	7,166	-22.5%	Shares	Sole	2024-08-06
2024-03-31	$376,045	9,244	-18.9%	Shares	Sole	2024-05-06
2023-12-31	$421,454	11,403	+85.2%	Shares	Sole	2024-02-06
2023-09-30	$235,235	6,158	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.